Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital

INTRODUCTION: Cancer patients are more vulnerable to coronavirus disease 2019 (COVID-19) owing to their compromised immune status. However, data regarding COVID-19 vaccine safety and immune response in cancer patients are scarce. METHOD: This prospective, age- and sex-matched, single-center cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Limpawittayakul, Piyarat, Sungkasubun, Prakongboon, Chaiwiriyawong, Worawit, Supavavej, Archara, Weerasubpong, Bowon, Siripaibun, Jomtana, Phanthunane, Chumut, Lamlertthon, Wisut, Ungtrakul, Teerapat, Tawinprai, Kriangkrai, Tantiyavarong, Walaipan, Samdaengpan, Chayanee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746434/
https://www.ncbi.nlm.nih.gov/pubmed/35976687
http://dx.doi.org/10.1080/21645515.2022.2104058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746434/
https://www.ncbi.nlm.nih.gov/pubmed/35976687
http://dx.doi.org/10.1080/21645515.2022.2104058

Ejemplares similares